JP2012046538A5 - - Google Patents

Download PDF

Info

Publication number
JP2012046538A5
JP2012046538A5 JP2011226655A JP2011226655A JP2012046538A5 JP 2012046538 A5 JP2012046538 A5 JP 2012046538A5 JP 2011226655 A JP2011226655 A JP 2011226655A JP 2011226655 A JP2011226655 A JP 2011226655A JP 2012046538 A5 JP2012046538 A5 JP 2012046538A5
Authority
JP
Japan
Prior art keywords
composition
peptide analog
seq
target muscle
promote
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011226655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012046538A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012046538A publication Critical patent/JP2012046538A/ja
Publication of JP2012046538A5 publication Critical patent/JP2012046538A5/ja
Pending legal-status Critical Current

Links

JP2011226655A 2003-01-21 2011-10-14 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法 Pending JP2012046538A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44177203P 2003-01-21 2003-01-21
US60/441,772 2003-01-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010215438A Division JP4913895B2 (ja) 2003-01-21 2010-09-27 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法

Publications (2)

Publication Number Publication Date
JP2012046538A JP2012046538A (ja) 2012-03-08
JP2012046538A5 true JP2012046538A5 (https=) 2012-04-19

Family

ID=32771972

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006501057A Withdrawn JP2006516287A (ja) 2003-01-21 2004-01-21 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法
JP2010215438A Expired - Fee Related JP4913895B2 (ja) 2003-01-21 2010-09-27 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法
JP2011226655A Pending JP2012046538A (ja) 2003-01-21 2011-10-14 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2006501057A Withdrawn JP2006516287A (ja) 2003-01-21 2004-01-21 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法
JP2010215438A Expired - Fee Related JP4913895B2 (ja) 2003-01-21 2010-09-27 Ｍｎｔｆペプチドおよび組成物ならびに使用の方法

Country Status (9)

Country Link
US (2) US7183373B2 (https=)
EP (1) EP1587526B1 (https=)
JP (3) JP2006516287A (https=)
AT (1) ATE530191T1 (https=)
AU (1) AU2004205659B2 (https=)
CA (1) CA2506855C (https=)
DK (1) DK1587526T3 (https=)
ES (1) ES2375797T3 (https=)
WO (1) WO2004065410A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841531B2 (en) 1996-09-27 2005-01-11 Genervon Biopharmaceuticals Llc Methods and use of motoneuronotrophic factors
ES2375797T3 (es) * 2003-01-21 2012-03-06 Genervon Biopharmaceuticals Llc Péptidos y compuestos de factores tróficos de motoneuronas y sus procedimientos de utilización.
CN101374537B (zh) * 2005-11-10 2016-04-20 健能万生物制药公司 干细胞的mntf分化和生长
US8340193B2 (en) * 2006-08-04 2012-12-25 Microsoft Corporation Wyner-Ziv and wavelet video coding
ES2407454T3 (es) * 2006-11-10 2013-06-12 Genervon Biopharmaceuticals Llc Métodos de tratamiento de trastornos neuronales utilizando péptidos MNTF y análogos de los mismos
EP2000134A1 (en) * 2007-06-06 2008-12-10 Neuraxo Biopharmaceuticals GmbH Use of a substance for the improvement of pns lesions
US20090233295A1 (en) * 2008-01-29 2009-09-17 Elias Georges Trim59 directed diagnostics for neoplastic disease
ES2569552T3 (es) * 2008-02-21 2016-05-11 Genervon Biopharmaceuticals Llc Composiciones de péptido de MNTF y métodos de uso
CN101952306B (zh) * 2008-02-21 2014-09-10 皮护神经科学协会 Mntf肽的化妆和皮肤病制剂
WO2016210123A1 (en) 2015-06-26 2016-12-29 Genervon Biopharmaceuticals, LLC Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease
CN117279657A (zh) 2021-05-18 2023-12-22 日本株式会社Ltt生物医药 用于治疗或预防伴随抗癌剂给药的障碍的医药组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309877B1 (en) * 1996-09-27 2001-10-30 Km Biotech, Inc. Polynucleotides encoding motoneuronotrophic factors
US6841531B2 (en) * 1996-09-27 2005-01-11 Genervon Biopharmaceuticals Llc Methods and use of motoneuronotrophic factors
ES2375797T3 (es) * 2003-01-21 2012-03-06 Genervon Biopharmaceuticals Llc Péptidos y compuestos de factores tróficos de motoneuronas y sus procedimientos de utilización.

Similar Documents

Publication Publication Date Title
JP2012046538A5 (https=)
Jansson et al. MicroRNA and cancer
GB201206559D0 (en) Polypeptide
JP2013544090A5 (https=)
JP2014240404A5 (https=)
CN103804482B (zh) 一种抗菌肽及其应用
JP2014530803A5 (https=)
MX366968B (es) Molecula de union al antigeno que induce la inmunorespuesta al antigeno objetivo.
EP4349359A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
JP2010534684A5 (https=)
JP2011177189A5 (https=)
JP2016527891A5 (https=)
JP2012529293A5 (https=)
RU2012120772A (ru) Варианты синтетической фитазы
MX352195B (es) Genes que proporcionan resistencia al mildiú polvoroso en cucumis melo.
JP2015533791A5 (https=)
JP2014532722A5 (https=)
MY169650A (en) Crystalline recombinant interferon with altered spatial configuration,three-dimensional structure and uses thereof
JP2014527801A5 (https=)
Wang et al. The versatile functions of LRR-only proteins in mollusk Chlamys farreri
JP2010265269A5 (https=)
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles
RU2014124139A (ru) Подобные коллагену гены шелка
JP2013504519A5 (https=)
WO2012118821A3 (en) Glucocorticoid induced leucine zipper mimetics as therapeutic agents in multiple sclerosis